Cancer research
Researchers at the Netherlands Cancer Institute, led by Gordon Watt, have been awarded a prestigious European Research Council grant to investigate the interaction between autoimmune diseases and cancer treatments, with a focus on reducing the risk of developing second breast cancers. The study aims to leverage novel molecular approaches and
Cancer research
Current study results reveal that cancer treatments have adverse effects on female fertility, leading to a growing number of girls and women facing reproductive health challenges. Researchers from the University of Colorado have found that radiation and chemotherapy can cause permanent damage to the ovaries and uterus, resulting in a
Cancer
Researchers from the School of Chemical and Pharmaceutical Engineering have made a significant discovery in the treatment of metastatic cancer. A new study published in the Chemical Engineering Journal has demonstrated the effectiveness of ultrasmall dendrimer nanodots in targeted chemotherapy and enhanced photodynamic/immunotherapy of metastatic cancer. The research has
Cancer research
Researchers at the First Affiliated Hospital of Anhui Medical University in China have discovered that circulating extrachromosomal circular DNA (eccDNA) in the plasma can be used as a biomarker to predict chemotherapy sensitivity in epithelial ovarian cancer (EOC) patients. The study, published in Experimental Cell Research, found that EOC patients
Cancer research
A recent study published in the BMC Cancer journal has highlighted the complexities in standardizing stereotactic ablative radiation therapy (SABR) for recurrent ovarian cancer. The research, funded by the Ministry of Health and Welfare, aimed to assess treatment planning consistency and protocol adherence in a prospective, randomized, multicenter phase III
Cancer
Research conducted at Peking University Cancer Hospital and Institute in Beijing, People's Republic of China, has shed light on the real-world pharmacological treatment patterns of neuropathic pain in China. The study, planned to involve approximately 600 patients with diabetic peripheral neuropathic pain (DPNP) and 400 with chemotherapy-induced peripheral
Cancer
D3 Bio, Inc, a clinical-stage oncology company, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to D3S-001, a next-generation KRAS G12C-selective inhibitor, for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received
Cancer research
Researchers at the Department of Hepatobiliary Surgery have made significant progress in understanding the complexities of biliary tract cancer, a highly aggressive form of cancer with limited therapeutic options. According to a new study, "Immunotherapy in biliary tract cancer: reshaping the tumour microenvironment and advancing precision combination strategies,"
Cancer research
Dermot Murnaghan, a former Sky News presenter, has spoken publicly about his stage four prostate cancer diagnosis, revealing that he "fell through the gaps" with early testing. Despite not having a national screening programme for prostate cancer due to the lack of a reliable test, Murnaghan encouraged men
Cancer
The Chemotherapy-Induced Febrile Neutropenia (CIN) pipeline is a rapidly growing area of research, with over four key companies actively developing more than four therapeutic candidates for CIN treatment. DelveInsight's "Chemotherapy Induced Febrile Neutropenia - Pipeline Insight, 2025" report provides a comprehensive analysis of the ongoing clinical
Cancer research
A new study conducted by researchers at Fujinomiya City General Hospital in Japan has provided valuable insights into the cost-effectiveness of various chemotherapy treatments for advanced and recurrent cervical cancer. The study, published in Frontiers in Health Services, reveals that traditional first-line platinum-based doublet chemotherapy is consistently found to be
Cancer
Researchers from the University of Torino, Italy, have published a new report on the impact of a rationally designed chemotherapy combination on the generation of hypermutation and immunogenicity in otherwise immune-refractory colorectal and breast cancer mouse models. The study investigated the effects of combining cisplatin and temozolomide on the immune
